compounded semaglutide safety concerns Patient Updates Semaglutide Compounding Safety Concerns: 10
Description
Grounded in Quality
SURMOUNT-1 subgroup data from 2,542 women showed tirzepatide produced ~23% body weight reduction in peri/postmenopausal women vs 3% on placebo
Lastly, Frssing et al
Nutrition counseling: Our registered dietitians can provide personalized dietary plans, education on healthy eating habits, and support for long-term maintenance
Our GLP-1 medications, including Semaglutide and Tirzepatide, mimic the effects of a natural hormone called GLP-1 (glucagon-like peptide-1), which plays a role in regulating appetite and blood sugar levels
